MAIN ARTICLE
A vast fund, not an immediate payout
According to Reuters, AP and Bayer’s announcement, St. Louis Circuit Judge Timothy Boyer found the agreement fair, reasonable and adequate. The $7.25 billion figure is a funding ceiling, including amounts already paid, rather than a single cheque to be distributed immediately. Monsanto is to make capped annual contributions that decline over a period of up to 21 years. It would therefore be misleading to divide that headline total equally among the roughly 65,000 claims Bayer had been facing in US courts.
First announced in February 2026, the arrangement is designed to address most existing and potential eligible claims alleging non-Hodgkin lymphoma after exposure to Roundup, subject to defined exposure and diagnosis windows. People who qualify will still have to navigate the claims administration process. Certain lawsuits remain outside the program, meaning that court approval does not eliminate every remaining dispute or guarantee an identical payment to each claimant.
Why approval came despite objections
Some objectors argued that expected individual awards were too modest compared with the amounts previously received by other Roundup plaintiffs. Judge Boyer weighed those concerns against the risk of forcing sick people into litigation that might take years and yield no compensation.
















